Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma

Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma

Abstract Background Transarterial chemoembolisation is the standard of care for intermediate stage (BCLC B) hepatocellular carcinoma, but it is challenging to decide when to repeat or stop treatment. Here we performed the first external validation of the SNACOR (tumour Size and Number, baseline Alph...

Full description

Bibliographic Details
Main Authors: Aline Mähringer-Kunz, Arndt Weinmann, Irene Schmidtmann, Sandra Koch, Sebastian Schotten, Daniel Pinto dos Santos, Michael Bernhard Pitton, Christoph Dueber, Peter Robert Galle, Roman Kloeckner
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Transarterial chemoembolisation
SNACOR
Online Access:http://link.springer.com/article/10.1186/s12885-018-4407-5

Internet

http://link.springer.com/article/10.1186/s12885-018-4407-5

Similar Items